Marie Skłodowska-Curie Actions (MSCA) aim to support the career development and training of researchers in all scientific disciplines through international and intersectoral mobility.
The fellows carry out their own research project in collaboration with a host institution, which is indicated at the time of their application. Researchers of all ages, nationalities and scientific disciplines can apply.
Postdoctoral Fellowships (MSCA-PF) provide an extremely enriching experience, that enhance the career perspectives for researchers by developing new scientific competences and gaining international and collaborative research experience.
There are more than 200 UCM research groups interested in hosting researchers through MSCA Postdoctoral Fellowships.
They are looking for ambitious, creative and scientifically curious researchers who meet the MSCA-PF eligibility criteria.
If you are ready to take the next step in your research career look into our university's host offers.
The Complutense University of Madrid as host institution, through a dedicated European Research Office, supports MSCA Postdoctoral Fellowship candidates both in the application process and in managing the grant.
We offer, among other specific support services, an in-depth review of the proposal by experienced advisors: internal deadline to send the draft proposal to office is August 31, 2021.
The next section include information about several UCM supervisors that have expressed their interests to host MSCA experienced researchers in their research group. If you are interested in one of them, you should contact the corresponding Scientific Supervisor directly.
The web search application will help you find the offer that best suits your interests. Just enable and use the filters (click on the filter icon). You can search by faculty, research area, and research topic to be proposed / description of the research group (by means of keywords). Visit the links provided in the search results (table below) to display further information.
Some offers the supervisors ask for particular documents. If you are required to submit a project proposal or you do not know exactly what send to present your candidature, you can use our template 'One Page Proposal'.
Neurodegenerative disorders: development of cannabinoid-based therapies
Biochemistry and Molecular Biology, Faculty of Medicine
Faculty / Institute
Institute of Neurochemistry Research
The group is located at the Department of Biochemistry and Molecular Biology in the Faculty of Medicine and is a member of the Complutense Institute of Neurochemistry Research, the IRYCIS and the CIBERNED. The PI is a Full Professor with more than 40 years of experience in the research in CNS disorders. He has published 249 research articles, 45 reviews and 43 book chapters, with a H-index of 70. The remaining members include senior researchers, postdoctoral and predoctoral researchers, Master and Degree students, and assistants, all with the necessary expertise in this research field. The presence of undergraduate and predoctoral students reflects the formative and training activity developed for many years by the group, reflected too in 21 doctoral thesis presented during the last 30 years, as well as in the long- or short-term visits carried out by numerous predoctoral and post-doctoral researchers coming from different countries. The group has received continuous funding during the last 30 years from national or international agencies, both public and private, and has maintained numerous collaborations with national or international groups working in the field of cannabinoids or CNS disorders, including a close collaboration with clinical groups (mainly in the field of Neurology) within the IRYCIS and CIBERNED. The group has also maintained an important transfer activity with patents and contracts with pharmaceutical or biotechnological companies in this research field
At present, the group is interested in the development of cannabinoid-based therapies for neurodegenerative disorders, for which it collaborates with different groups of Medicinal Chemistry or with pharmaceutical companies working in the development of cannabinoid-based medicines (e.g GW Pharmaceuticals, UK; Emerald Health Pharmaceuticals, USA; Emerald Health Biotechnology-Spain; Symrise, Germany; ANKAR Pharma, Spain; Roche, Switzerland). The group is contributing in these collaborations with the biological characterization of phytocannabinoids and derivatives, as well as of new cannabinoid compounds, in relation with the identification of their pharmacological targets (mainly their activity at CB1/CB2 receptors but also GPR55 receptors), possible combinations of compounds and pharmacological synergies, biological activity in in vitro models, and therapeutic effects in in vivo models of different neurodegenerative disorders, including Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis/frontotemporal dementia, and autosomal-dominant cerebellar ataxias. The group is particularly interested in developing disease-modifying cannabinoid-based therapies for these disorders, but also in the investigation of the role of the signaling system, the so-called endocannabinoid system, which contains the different targets for these therapies, in the pathogenesis of these disorders. These studies have progressed up to the development of clinical trials in some disorders (e.g. Huntington's disease), pending of this clinical validation after an intense and positive preclinical work (e.g. Parkinson's disease, amyotrophic lateral sclerosis), or in the stage of preclinical validation (e.g. frontotemporal dementia, autosomal-dominant cerebellar ataxias)
Life Sciences (LIF)
Pza. Ramón y Cajal, s/n; Ciudad Universitaria; 28040 - MADRID
Tenure-Track Position for Marie Skłodowska-Curie Global Fellowships?
The "Plan de Actuaciones en Profesorado 2020-23 (ES)" of the Complutense University includes among its calls several options for further hiring of researchers with a PhD. All options require an excellent CV and being granted National Accreditation.
Among the requirements for the stabilization of a Researcher to Assistant Professor, it is required that the researcher has spent at least 3 years as a researcher hired by the UCM in a competitive public call.
Global Fellowships are open to researchers currently within or outside Europe who want to move to a Third Country for 1-2 years and then come back to the Complutense University for an additional year. Therefore, researchers who have been awarded a three-year Global Fellowship would be, after the end of the project and with the current regulatory framework, in a position to meet this condition.
In certain situations, it has been possible for a researcher with at least 2 years working at UCM to opt for a position as a junior Associate Professor.